Home Alzheimer’s Disease Stephen Schuster, MD, on Prioritizing Patients with Aggressive Lymphomas During COVID-19 Pandemic

Stephen Schuster, MD, on Prioritizing Patients with Aggressive Lymphomas During COVID-19 Pandemic

Stephen Schuster, MD, discussed how they are prioritizing patients with more aggressive lymphomas, with an emphasis on tumor volume and serum LDH levels during the COVID-19 pandemic.

Transcription:

We’ve gotten very good at assessing risk for not making it to collection. Basically, the 2 primary variables that we found are the tumor volume, the bulk of tumor that a patient has, also the serum LDH which effects the proliferative capacity or growth rate of the tumor. Patients with high serum LDH and high tumor volume are less likely to stay stable. Again, these are all patients that are refractory to existing therapy so it’s hard to keep them stable, although we try some things for so called ‘bridging’: steroids, novel agents, lenalidomide, ibrutinib for some patients, which occasionally will work. In these high volume, very-high risk for rapid progression, in those cases…

Continue Reading to the Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Parasite found in undercooked meat linked with risk of rare brain cancer

submitted by /u/Meat_Mithkabob Continue Reading to the Source

Living up to expectations : braincancer

Hey everyone!I wrote a little something about some of the comments you often hear from others and how sometimes you feel like you need...

My Brain Tumor Taught Me To Shift My Perspective on These 5 Things

submitted by /u/andrewjoegeorge Continue Reading to the Source

Recent Comments